Raymond J. Furey - Feb 28, 2024 Form 4 Insider Report for RIGEL PHARMACEUTICALS INC (RIGL)

Role
EVP, GC, CCO & Corp Sec
Signature
/s/ Raymond F. Furey
Stock symbol
RIGL
Transactions as of
Feb 28, 2024
Transactions value $
$0
Form type
4
Date filed
3/1/2024, 07:14 PM
Previous filing
Jan 25, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RIGL Employee Stock Option (right to buy) Award $0 +93.8K $0.00 93.8K Feb 28, 2024 Common Stock 93.8K $0.90 Direct F1, F3
transaction RIGL Employee Stock Option (right to buy) Award $0 +78.5K $0.00 78.5K Feb 28, 2024 Common Stock 78.5K $1.27 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person was granted an option with a performance-based condition with respect to 93,750 shares of the issuer's common stock on December 8, 2022. Thus, the exercise price of this option is $0.8965 (the closing price of the issuer's common stock on Nasdaq the date of grant). In light of the performance-based vesting condition of this grant, the grant was not reportable under Section 16 until the performance metric was satisfied. On February 28, 2024, it was determined that the performance metric had been met.
F2 The Reporting Person was granted an option with a performance-based condition with respect to 78,500 shares of the issuer's common stock on January 23, 2024. Thus, the exercise price of this option is $1.27 (the closing price of the issuer's common stock on Nasdaq the date of grant). In light of the performance-based vesting condition of this grant, the grant was not reportable under Section 16 until the performance metric was satisfied. On February 28, 2024, it was determined that the performance metric had been met.
F3 The option was fully vested on February 28, 2024, the date the determination was made that the performance metric had been met.